Author

C. Bastos

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:imaging· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

A. Barreto da Silva· 1 shared A. Dabrowska· 1 shared A. Fathima· 1 shared A. Keita· 1 shared A. P. Brown· 1 shared A. Petrin· 1 shared B. Chamberlain· 1 shared B. K. Allen· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Barreto da Silva

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Immunocompetent Cell Targeting by Food-Additive Titanium Dioxide

J. W. Wills, A. Dabrowska, J. Robertson, M. Miniter, S. Riedle, H. Summers, R. Hewitt, A. Fathima, A. Barreto da Silva, C. Bastos, S. Micklethwaite, A. Keita, J. Soderholm, N. Roy, D. Otter, , J. J. Powell

This study identifies immunocompetent cells that accumulate food-grade titanium dioxide in vivo and demonstrates a mouse model for assessing human-relevant risks of ingested nanoparticles.

bioRxiv · Apr 16, 2024Pharmacology & Toxicology

Design of a systemic small molecule clinical STING agonist using physics-based simulations and artificial intelligence

B. K. Allen, M. M. Kulkarni, B. Chamberlain, T. Dwight, C. Koh, R. Samant, F. Jernigan, J. Rice, D. Tan, S. Li, K. Marino, H. Huang, E. Chiswick, B. Tesar, S. Sparks, , W. Sherman

This paper designs a small molecule STING agonist, SNX281, using computational methods and AI, showing systemic activity and antitumor effects in mice.

bioRxiv · May 23, 2022 · PreprintCancer Biology